CAO Bing, JI Tao, ZHOU Bin, JIAO Guoqing, ZOU Jian. Significance of microRNA-155 expression in gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (21): 43-45. DOI: 10.7619/jcmp.201321012
Citation: CAO Bing, JI Tao, ZHOU Bin, JIAO Guoqing, ZOU Jian. Significance of microRNA-155 expression in gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (21): 43-45. DOI: 10.7619/jcmp.201321012

Significance of microRNA-155 expression in gastric cancer

More Information
  • Published Date: April 07, 2014
  • 刘霞, 代荫梅, 张为远. MicroRNA在妇科肿瘤中的研究进展 [J]. {H}中华医学杂志, 2009, (5):357.doi: 10.3760/cma.j.issn.0376-2491.2009.05.019.
    Xiang X, Zhuang X, Ju S. miR-155promotes macroscopic tumor formation yet inhibits tumor dissemination from mammary fat pads to the lung by preventing EMT [J]. {H}ONCOGENE, 2011.3440.
    Gironella M, Seux M, Xie M J. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development [J]. Prec Natl Acad Sci USA, 2007.16170.
    Guo H Q, Huang G L, Guo C C. Diagnostic and prognostic value of circμLating miR-221 for extranodal natural killer/T-cell lymphoma [J]. DisMarkers, 2010(5):251.
    Huang Z, Huang D, Ni S. Plasma microRNAs are promising novel biomarkers forearly detection of colorectal cancer [J]. {H}International Journal of Cancer, 2010(1):118.
    Brase J C, Johannes M, Schlomm T. CircμLating miRNAs are correlated with tumor progression in prostate cancer [J]. {H}International Journal of Cancer, 2011(3):608.
    Li A, Omura N, Hong S M. Pancreatic cancers epigenetically silence SIPI and hypomethylate and over express miR-200a/200b in association with elevated circμLating miR-200a and miR-200b levels [J]. {H}CANCER RESEARCH, 2010, (13):5226.
  • Related Articles

    [1]ZHANG Lanfang, CHEN Xu, KUAI Jun, QIN Lei, YANG Yan, CHANG Tingmin. Effect of tegafur, gimeracil and oteracil potassium combined with oxaliplatin on gastric motility-related hormones, matrix metalloproteinase-2 and matrix metalloproteinase-9 in elderly patients with gastric cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(12): 57-60, 65. DOI: 10.7619/jcmp.20241047
    [2]ZHENG Leizhen, LIU Xianli. Comparison in efficacy of neoadjuvant chemotherapies combined with surgery for advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 26-29. DOI: 10.7619/jcmp.20201637
    [3]ZHOU Wei, CHEN Quanquan, LUO Hongmei. Efficacy and safety of XELOX and FOLFOX4 regimens in the treatment of patients with advanced gastric carcinoma[J]. Journal of Clinical Medicine in Practice, 2016, (9): 64-66. DOI: 10.7619/jcmp.201609018
    [4]ZHANG Songzhen, XUE Qiaoyun, CHENG Shuying. Effect of shenqi fuzheng injection on immune function of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2016, (7): 48-51. DOI: 10.7619/jcmp.201607014
    [5]CHENG Xiaofei. Clinical research on TGOPC combined with docetaxel and platinum in treatment of patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2015, (19): 22-25. DOI: 10.7619/jcmp.201519007
    [6]Efficacy and safety of TOF and SOX regimens in the treatment of advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2013, (21): 66-68,76. DOI: 10.7619/jcmp.201321018
    [7]ZHANG Chunlin, ZHAO Lin. Clinical application of neoadjuvant therapy in advanced gastric cancer and its effect on prognosis[J]. Journal of Clinical Medicine in Practice, 2013, (21): 46-49. DOI: 10.7619/jcmp.201321013
    [8]ZHUANG Min, ZHANG Wei-min, LIU Xiao-qing. The clinical study of domestic compound Tegafur capsulecombined with Paclitaxel second-line therapy for patients with advanced or metastatic gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (15): 94-96. DOI: 10.3969/j.issn.1672-2353.2011.15.034
    [9]ZHAO Xiao-guang, ZHANG Yan-zhu. Clinical investigation of S-1 alone in the treatment of elderly patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036
    [10]WANG Si-liang, CHEN Xiao-dong, WU Rong, QIAN Hao-chu. Clinical observation of Docetaxel combined with FOLFOX on advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (9): 59-61. DOI: 10.3969/j.issn.1672-2353.2011.09.019

Catalog

    Article views (121) PDF downloads (7) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return